Amedeo's Top 20

Amedeo Smart

Independent Medical Education

03 April 2023

Multidisciplinary Journal Club

  1. Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, et al.
    Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus.
    N Engl J Med 2023;388:980-990.

  1. Ghany MG, Saraswat VA.
    Patients With Compensated Hepatitis B Virus-Related Cirrhosis and Low-Level Viremia: Treat or Not to Treat?
    Am J Gastroenterol 2023.

  2. Giraldez-Gallego A, Rodriguez-Seguel EDP, Valencia-Martin R, Morillo-Garcia A, et al.
    Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial.
    Gut 2023.

  3. Taipale H, Tanskanen A, Tiihonen J.
    Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia.
    Am J Psychiatry 2023.

  4. Wewege MA, Bagg MK, Jones MD, Ferraro MC, et al.
    Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis.
    BMJ 2023;380:e072962.

  1. Vich Vila A, Hu S, Andreu-Sanchez S, Collij V, et al.
    Faecal metabolome and its determinants in inflammatory bowel disease.
    Gut 2023.

  2. Schlegel A, Mueller M, Muller X, Eden J, et al.
    A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation.
    J Hepatol 2023;78:783-793.

  3. Allard-Gray A, Boakye I, Camara A, Eisenbeis L, et al.
    Factors Associated with Discontinuation of Tuberculosis Preventive Treatment: Post-Hoc Analysis of Two Randomized Controlled Trials.
    Clin Infect Dis 2023.

  4. Plichta JK, Thomas SM, Hayes DF, Chavez-MacGregor M, et al.
    Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.
    J Clin Oncol 2023.

  5. Lu X, Zhou ZY, Xin Y, Wang MJ, et al.
    Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis.
    Inflamm Bowel Dis 2023.

  1. Flechl B, Konrath L, Lutgendorf-Caucig C, Achtaewa M, et al.
    Preservation of Neurocognition after Proton Beam Radiation Therapy for Intracranial Tumors: First Results from REGI-MA-002015.
    Int J Radiat Oncol Biol Phys 2023;115:1102-1114.

  2. Rajagopalan S, Sarwal A.
    Neuromonitoring in Critically Ill Patients.
    Crit Care Med 2023;51:525-542.

  3. Russo CV, Sacca F, Braca S, Sansone M, et al.
    Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.
    Cephalalgia 2023;43:333102423116180.

  4. Nguyen-Buckley C, Bezinover DS, Bhangui P, Biancofiore G, et al.
    International Liver Transplantation Society/Society for Advancement of Transplant Anesthesia Consensus Statement on Essential Attributes of a Liver Transplant Anesthesiologist.
    Transplantation 2023.

  5. Kudrow D, Dafer R, Dodick DW, Starling A, et al.
    Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.
    Headache 2023;63:418-428.

  1. Rose D, Cavalier A, Kam W, Cantrell S, et al.
    Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Stroke 2023.

  2. Gairing SJ, Mangini C, Zarantonello L, Gioia S, et al.
    Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: a multicenter study.
    Am J Gastroenterol 2023.

  3. Kahn RS, Kane JM, Correll CU, Arevalo C, et al.
    Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study.
    J Clin Psychiatry 2023;84.

  4. Sehatpour P, Iosifescu DV, De Baun HM, Shope C, et al.
    Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine.
    Biol Psychiatry 2023.

  5. Kochunov P, Ma Y, Hatch KS, Gao S, et al.
    Ancestral, Pregnancy, and Negative Early Life Risks Shape Children's Brain Dis/Similarity to Schizophrenia.
    Biol Psychiatry 2023.


more..

Privacy Policy